Background incidence rates from electronic healthcare databases for vaccine safety monitoring: review of challenges from the COVID-19 vaccination campaign and proposal for best practices.
Saved in:
| Title: | Background incidence rates from electronic healthcare databases for vaccine safety monitoring: review of challenges from the COVID-19 vaccination campaign and proposal for best practices. |
|---|---|
| Authors: | Gandhi-Banga S; Epidemiology and Benefit Risk, Patient Safety and Pharmacovigilance, Sanofi, Toronto, ON, Canada., Serradell L; Epidemiology and Benefit Risk, Patient Safety and Pharmacovigilance, Sanofi, Lyon, France., Layton D; PEPI Consultancy Limited, Southampton, United Kingdom., Dreyfus J; Global Medical Epidemiology, Pfizer, Inc, New York, NY, United States., Praet N; Global Epidemiology Organization, Johnson and Johnson, Beerse, Belgium., Garofalo DC; Global Medical Epidemiology, Pfizer, Inc, New York, NY, United States., Bauchau V; Independent, Previously Vaccine Safety, GlaxoSmithKline (GSK), Wavre, Belgium., Kelly SP; Global Medical Epidemiology, Pfizer, Inc, New York, NY, United States., Li L; Epidemiology and Benefit Risk, Patient Safety and Pharmacovigilance, Sanofi, Morristown, NJ, United States. |
| Source: | Frontiers in drug safety and regulation [Front Drug Saf Regul] 2025 Dec 01; Vol. 5, pp. 1651090. Date of Electronic Publication: 2025 Dec 01 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 9919033103806676 Publication Model: eCollection Cited Medium: Internet ISSN: 2674-0869 (Electronic) Linking ISSN: 26740869 NLM ISO Abbreviation: Front Drug Saf Regul Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2674-0869 |
|---|---|
| DOI: | 10.3389/fdsfr.2025.1651090 |
